L3VLUP
ProSign in

MMM · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

MMMJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • MMM
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterMMMJNJ
Q3 202022 holders, $4.1bn30 holders, $26.2bn
Q4 202020 holders, $4.3bn32 holders, $26.6bn
Q1 202116 holders, $4.6bn31 holders, $25.3bn
Q2 202115 holders, $5.1bn37 holders, $25.6bn
Q3 202117 holders, $4.0bn40 holders, $24.1bn
Q4 202117 holders, $3.6bn33 holders, $25.2bn
Q1 202218 holders, $2.2bn35 holders, $28.2bn
Q2 202221 holders, $2.0bn33 holders, $26.9bn
Q3 202226 holders, $2.2bn36 holders, $25.4bn
Q4 202222 holders, $2.1bn35 holders, $27.6bn
Q1 202321 holders, $1.8bn42 holders, $24.5bn
Q2 202321 holders, $1.8bn38 holders, $25.0bn
Q3 202323 holders, $1.8bn37 holders, $18.9bn
Q4 202327 holders, $2.5bn31 holders, $19.0bn
Q1 202429 holders, $3.3bn32 holders, $19.7bn
Q2 202430 holders, $4.8bn35 holders, $20.4bn
Q3 202434 holders, $5.9bn28 holders, $22.3bn
Q4 202433 holders, $5.8bn37 holders, $20.4bn
Q1 202526 holders, $7.2bn32 holders, $20.5bn
Q2 202521 holders, $6.9bn31 holders, $18.4bn
Q3 202524 holders, $6.8bn32 holders, $23.7bn
Q4 202520 holders, $6.6bn29 holders, $27.8bn
Q1 202626 holders, $7.0bn34 holders, $35.6bn
Q2 202631 holders, $7.1bn33 holders, $39.1bn
MMM

3M Co

Holders
21
Reported value
$6.9bn
Buyers
7
Sellers
15

Breadth -8 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
JNJ

Johnson & Johnson

Holders
31
Reported value
$18.4bn
Buyers
15
Sellers
16

Breadth -1 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2025

Among the 39 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only MMM (8)

ARK Investment Management LLC, Capital World Investors, Citadel Advisors LLC, Freestone Grove Partners LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Moore Capital Management LP, Schonfeld Strategic Advisors LLC

Only JNJ (18)

Bridgewater Associates LP, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., GAMCO Investors Inc, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Point72 Asset Management LP, Quantbot Technologies LP, Renaissance Technologies LLC, Two Sigma Advisers LP, Two Sigma Investments LP, Verition Fund Management LLC, Wellington Management Group LLP, Winton Group Ltd, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →